A 23-year male presented for a routine ophthalmic examination, with visual acuity 20/20 OU. Slit lamp examination revealed bilateral inferior corneal pigmentation, involving the anterior cornea, at the level of epidermis and anterior stroma \[[Fig. 1](#F1){ref-type="fig"}\]. Posterior segment examination was unremarkable. There was history of ingestion of desvenlaxafine 50 mg and clonazepam 0.5 mg OD since last 2 years for depression. Desvenlaxafine and clonazepam are oral selective serotonin and norepinephrine reuptake inhibitor (SSRI) and benzodiazepine, respectively. Many drugs can present with corneal pigmentation,\[[@ref1][@ref2][@ref3]\] but such pigmentation with SSRIs has not been reported. With increasing dosage, retinal, and/or lenticular pigmentation can occur causing visual impairment, hence warranting periodic ocular examination in such patients.

![(a) Diffuse illumination showing inferior corneal pigmentation from 4 o\' clock to 8 o\' clock position. (b) Slit view showing inferior corneal pigmentation, from 4 o\' clock to 8 o\' clock position, in anterior cornea, at the level of epidermis and anterior stroma (arrow)](IJO-68-917-g001){#F1}
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